← Evidence map

ArticleCurrent oncology (Toronto, Ont.)2026

Prognostic Impact of the Systemic Immune-Inflammation Index According to Concurrent Chemotherapy Backbone in Stage III Non-Small Cell Lung Cancer.

Aykut Demirkıran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Prognostic Impact of the Systemic Immune-Inflammation Index According to Concurrent Chemotherapy Backbone in Stage III Non-Small Cell Lung Cancer. | OpenQuestion